In AML, MEF2C has been found to be overexpressed in distinct molecular subsets of adult onset AML, including mixed lineage leukemia (MLL) gene-rearranged and ectropic virus integration site 1 (EVI1)-overexpressing leukemias [11]. Here, KMT2A is linked to acute myeloid leukemia.